Israel Englander Point Biopharma Global Inc. Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$6.78 - $8.1 $1.97 Million - $2.35 Million
-290,272 Reduced 49.97%
290,618 $2.11 Million
Q4 2022

Feb 14, 2023
BUY
$5.72 - $9.78 $1.26 Million - $2.15 Million
220,029 Added 60.97%
580,890 $4.24 Million
Q3 2022

Nov 14, 2022
BUY
$7.24 - $10.31 $2.61 Million - $3.72 Million
360,861 New
360,861 $2.79 Million

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email